Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy
NCT02637700
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Small Fiber Neuropathy
Interventions
DRUG:
Intravenous Immunoglobulin
DRUG:
Placebo
Sponsor
Academisch Ziekenhuis Maastricht